TR201900213T4 - Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu. - Google Patents

Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu. Download PDF

Info

Publication number
TR201900213T4
TR201900213T4 TR2019/00213T TR201900213T TR201900213T4 TR 201900213 T4 TR201900213 T4 TR 201900213T4 TR 2019/00213 T TR2019/00213 T TR 2019/00213T TR 201900213 T TR201900213 T TR 201900213T TR 201900213 T4 TR201900213 T4 TR 201900213T4
Authority
TR
Turkey
Prior art keywords
cell culture
production
continuous cell
polypeptide
related virus
Prior art date
Application number
TR2019/00213T
Other languages
English (en)
Turkish (tr)
Inventor
Grillberger Leopold
Reiter Manfred
Fleischanderl Daniel
Original Assignee
Baxalta GmbH
Baxalta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta GmbH, Baxalta Inc filed Critical Baxalta GmbH
Publication of TR201900213T4 publication Critical patent/TR201900213T4/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/006Cell injection or fusion devices
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0056Xeno-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/98Xeno-free medium and culture conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/00051Methods of production or purification of viral material
    • C12N2710/00052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24087ADAMTS13 endopeptidase (3.4.24.87)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
TR2019/00213T 2009-07-31 2010-08-02 Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu. TR201900213T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23031309P 2009-07-31 2009-07-31

Publications (1)

Publication Number Publication Date
TR201900213T4 true TR201900213T4 (tr) 2019-02-21

Family

ID=42668436

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/00213T TR201900213T4 (tr) 2009-07-31 2010-08-02 Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu.

Country Status (22)

Country Link
US (4) US8580554B2 (enExample)
EP (2) EP3480292A1 (enExample)
JP (2) JP5808742B2 (enExample)
KR (2) KR101885046B1 (enExample)
CN (1) CN102549142B (enExample)
AU (1) AU2010277490B2 (enExample)
BR (1) BR112012002137B8 (enExample)
CA (1) CA2769354A1 (enExample)
CO (1) CO6491119A2 (enExample)
DK (1) DK2459697T3 (enExample)
EA (1) EA022219B1 (enExample)
ES (1) ES2705206T3 (enExample)
HR (1) HRP20182165T1 (enExample)
IN (1) IN2012DN00899A (enExample)
MX (2) MX2012001274A (enExample)
NZ (1) NZ597742A (enExample)
PL (1) PL2459697T3 (enExample)
PT (1) PT2459697T (enExample)
SG (1) SG178176A1 (enExample)
SI (1) SI2459697T1 (enExample)
TR (1) TR201900213T4 (enExample)
WO (1) WO2011012725A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE11738351T2 (hu) 2010-07-08 2019-03-28 Baxalta GmbH Eljárás rekombináns ADAMTS13 elõállítására sejttenyészetben
SI2665806T1 (sl) * 2011-01-17 2021-11-30 F. Hoffmann-La Roche Ag Aparat za separacijo
US9115381B2 (en) 2011-05-13 2015-08-25 Octapharma Ag Method of increasing the productivity of eucaryotic cells in the production of recombinant FVIII
KR20230114317A (ko) 2011-07-01 2023-08-01 암젠 인크 포유동물 세포 배양
CN203129697U (zh) 2013-02-05 2013-08-14 客贝利(厦门)休闲用品有限公司 一种帐篷架杆
JP6280869B2 (ja) 2011-11-24 2018-02-14 ジェネトン 工業的な医薬用途に適合する拡張可能なレンチウイルスベクター製造システム
US9574167B2 (en) 2013-02-15 2017-02-21 Pharyx, Inc. Methods and apparatus for independent control of product and reactant concentrations
EP2964663A2 (en) 2013-03-08 2016-01-13 Genzyme Corporation Continuous purification of therapeutic proteins
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
EP2976418B1 (en) 2013-03-19 2020-09-30 CMC Biologics A/S A method for producing a product (e.g. polypeptide) in a continuous cell culture fermentation process.
ES2778928T3 (es) * 2013-08-30 2020-08-12 Glaxosmithkline Biologicals Sa Producción a gran escala de virus en cultivos celulares
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
WO2015149143A2 (en) 2014-04-01 2015-10-08 Advantech Bioscience Farmacêutica Ltda. Stable factor viii formulations with low sugar-glycine
CN106456720A (zh) 2014-04-01 2017-02-22 爱德技术生物科学有限公司 在无钙作为赋形剂下因子viii的稳定性
EP3158055B1 (en) * 2014-06-13 2019-09-11 CSL Limited Improved production of recombinant von willebrand factor in a bioreactor
CN116083345A (zh) * 2016-01-26 2023-05-09 勃林格殷格翰国际公司 对连续流动搅拌釜反应器细胞培养系统的连接灌注
KR102414290B1 (ko) 2016-04-15 2022-06-29 베링거 인겔하임 인터내셔날 게엠베하 세포 보유 장치 및 방법
HRP20210163T1 (hr) * 2016-12-21 2021-03-19 F. Hoffmann - La Roche Ag Kontrola rasta eukariotskih stanica
IL321253A (en) 2018-05-01 2025-08-01 Amgen Inc Antibodies with a modulated glycan profile
WO2019239780A1 (ja) * 2018-06-15 2019-12-19 富士フイルム株式会社 細胞培養方法、細胞培養装置、及び生産物の製造方法
CA3110666A1 (en) 2018-08-31 2020-03-05 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
CN113355297A (zh) * 2021-06-23 2021-09-07 吉林冠界生物技术有限公司 一种灌流式培养全悬浮mdck细胞生产重组禽流感病毒的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019512A (en) 1989-03-17 1991-05-28 Baxter International Inc. Spin filter for removing substantially cell-free culture medium from suspension cell culture system
US5626734A (en) 1995-08-18 1997-05-06 University Technologies International, Inc. Filter for perfusion cultures of animal cells and the like
JP4361730B2 (ja) 2000-10-02 2009-11-11 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト ビタミンk−依存性タンパク質の生成方法
AU2002342922A1 (en) * 2001-11-28 2003-06-10 Sandoz Ag Cell culture process
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
PL1902141T3 (pl) 2005-06-17 2012-12-31 Baxalta Inc Kompozycje o działaniu trombolitycznym zawierające ADAMTS13
CA2633306A1 (en) * 2006-01-04 2007-07-12 Baxter International Inc. Oligopeptide-free cell culture media
AU2008345231B2 (en) * 2007-12-27 2014-09-11 Takeda Pharmaceutical Company Limited Cell culture processes

Also Published As

Publication number Publication date
EA022219B1 (ru) 2015-11-30
DK2459697T3 (en) 2019-01-28
US20190153400A1 (en) 2019-05-23
EP2459697B1 (en) 2018-10-17
EP2459697A1 (en) 2012-06-06
JP6177260B2 (ja) 2017-08-09
KR20170077286A (ko) 2017-07-05
MX2012001274A (es) 2012-06-01
US10221400B2 (en) 2019-03-05
BR112012002137B1 (pt) 2020-04-14
US10745672B2 (en) 2020-08-18
BR112012002137B8 (pt) 2020-05-12
CN102549142A (zh) 2012-07-04
MX353610B (es) 2018-01-18
KR101752789B1 (ko) 2017-06-30
EP3480292A1 (en) 2019-05-08
US20140038264A1 (en) 2014-02-06
US20180051261A1 (en) 2018-02-22
EA201270213A1 (ru) 2012-06-29
NZ597742A (en) 2014-02-28
PT2459697T (pt) 2019-01-21
JP2013500710A (ja) 2013-01-10
HRP20182165T1 (hr) 2019-03-08
JP5808742B2 (ja) 2015-11-10
US8580554B2 (en) 2013-11-12
SG178176A1 (en) 2012-03-29
CN102549142B (zh) 2014-07-16
CO6491119A2 (es) 2012-07-31
KR101885046B1 (ko) 2018-08-02
KR20120038531A (ko) 2012-04-23
ES2705206T3 (es) 2019-03-22
US20110086411A1 (en) 2011-04-14
IN2012DN00899A (enExample) 2015-04-03
WO2011012725A1 (en) 2011-02-03
CA2769354A1 (en) 2011-02-03
US9650612B2 (en) 2017-05-16
AU2010277490A1 (en) 2012-02-09
WO2011012725A8 (en) 2011-05-05
SI2459697T1 (sl) 2019-03-29
BR112012002137A2 (pt) 2015-09-15
PL2459697T3 (pl) 2019-04-30
JP2015062436A (ja) 2015-04-09
AU2010277490B2 (en) 2014-08-28

Similar Documents

Publication Publication Date Title
TR201900213T4 (tr) Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu.
MX355650B (es) Produccion de proteinas en medios de cultivo de celulas libres de glutamina.
EA201492183A1 (ru) Клетки для получения рекомбинантной идуронат-2-сульфатазы
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
MY181513A (en) Cell culture compositions and methods for polypeptide production
EA201171018A1 (ru) Биореактор для культивирования клеток млекопитающих
WO2008154014A3 (en) A method for culturing mammalian cells to improve recombinant protein production
MX384960B (es) Cultivo celular metabolicamente optimizado
EA201391826A1 (ru) Культивирование клеток млекопитающих
MX356756B (es) Células madre pluripotentes en microportadores.
MY161866A (en) Cell culture improvements
AR083354A1 (es) Polipeptidos variantes cbh i (celobiohidrolasas i) con reducida inhibicion de producto
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
BR112014014116A2 (pt) método de floculação
WO2012145759A3 (en) Methods of protein production and compositions thereof
BR112015022529A2 (pt) meios de cultura de células e processos de produção de anticorpo
WO2012103496A3 (en) Expression of soluble viral fusion glycoproteins in mammalian cells
EA201170025A1 (ru) Способы повышения жизнеспособности и продукции культуры клеток
EA200900984A1 (ru) Улучшение клеточного роста
SG196723A1 (en) Purification of cell culture derived alpha1 protease inhibitor
WO2011086447A3 (en) Fermentation process for the preparation of recombinant heterologous proteins
MX2015010887A (es) Formulaciones y metodos para aumentar la produccion de proteinas recombinantes.
EA201201620A1 (ru) Способ получения рнк-вируса
AR118125A2 (es) Péptido, composición, método para identificar células t específicas de péptido fviii, proteína de fusión y método para preparar un péptido fviii
WO2011028623A3 (en) Modified organisms for improved saccharification of biomass